Remdesivir Helps Reduce COVID-19 Recovery Time: Vanderbilt University Medical Center
June 05, 2020
June 05, 2020
NASHVILLE, Tennessee, June 5 -- Vanderbilt University Medical Center issued the following news:
The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results (https://www.nejm.org/doi/full/10.1056/NEJMoa2007764query=featured_home) of a clinical trial published last month in The New England Journal of Medicine.
While a lower percentage of patients receiving remdesivir died during the . . .
The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results (https://www.nejm.org/doi/full/10.1056/NEJMoa2007764query=featured_home) of a clinical trial published last month in The New England Journal of Medicine.
While a lower percentage of patients receiving remdesivir died during the . . .